 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
FIBROTEST AT THE AASLD 2008 The AASLD (American Assosiation for the Study of Liver Disease), the most important medical congress in the liver disease field gathering thousands of hepatology specialists from all over the world, took place in San Francisco from October 31 to November 4, 2008. There has never been so much talk about non-invasive liver tests before. For the first time, this hepatology conference brought together two important events:
This year non-invasive assessment of liver fibrosis was one the most important topics indicated by the scientific committee of the Liver Meeting. During these parallel conferences, more that 20 scientific studies, three General Assemblies and two special sessions discussed non-invasive approaches for the diagnosis of liver fibrosis, which continue to have a growing recognition and in which FibroTest (Biopredictive S.A.S, France) is the leader and pioneer. The AASLD conferences provided a positive coverage for non-invasive liver disease tests and from now on, the experts’ opinions on “modern” diagnostic tools will include the non-invasive assessment of hepatic fibrosis. During a plenary session in which the subject “Non-invasive markers of fibrosis” was chosen by the AASLD President, an update on non-invasive biomarkers and their clinical utility was provided to optimize the management and the follow-up of patients with fibrotic liver disease. FibroTest, as the most validated non-invasive serum biomarker, was one of the main focus with a large number of presentations, sessions and workshops during the Liver Meeting 2008. KEY PRESENTATIONS, POSTERS AND STUDIES AT THE LIVER MEETING 2008 FIBROTEST VALIDATIONS T.POYNARD AND AL; SCREENING FOR ADVANCED FIBROSIS USING NON-INVASIVE BIOMARKERS, FIBROTEST AND FIBROSCAN IN A COMMUNITY BASED POPULATION. Fibrosis and cirrhosis screening without biopsy in the general population (French Social Security System). T.POYNARD AND AL; DIAGNOSTIC AND 10-YEAR PROGNOSTIC VALUES OF NON-INVASIVE BIOMARKERS OF FIBROSIS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE Prognostic value of FibroTest for 10-year survival without complications in alcoholic liver disease. Y.NGO AND AL; A PROSPECTIVE STUDY OF FIBROTEST-FIBROSURE PROGNOSITC VALUE AT 10 YEARS IN PATIENTS WITH CHRONIC HEPATITIS C Prognostic value of FibroTest for 10-year survival without complications in Hepatitis C. D. LAU-CORONA AND AL; EFFECTIVE USE OF FIBROTEST TO GENERATE DECISION TREES IN HEPATITIS C Independent validation of FibroTest compared to biopsy in Hepatitis C (independent study) L.ADAMS AND AL; NON-INVASIVE PREDICTION OF LIVER FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE Independent validation of FibroTest compared to biopsy in nonalcoholic steatosis with Hepascore (Independent study) L.CASTERA AND AL; PREVALENCE AND CAUSES OF DISCORDANCE BETWEEN FIBROSCAN AND FIBROTEST FOR FIRST-LINE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS C: A PROSPECTIVE ANALYSIS OVER 4 YEARS IN 3148 PATIENTS Discordance analysis between the results of FibroTest, Fibroscan and biopsy (Independent study) MIREEN FRIEDRICH-RUST AND AL; ACOUSTIC RADIATION FORCE ELASTOGRAPHY VERSUS TRANSIENT ELASTOGRAPHY FOR NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN VIRAL HEPATITIS: A NEW ALTERNATIVE? Diagnostic value of FibroTest compared to ARFI (Independent study) M.MUNTEANU AND AL; FIBROTEST DIAGNOSTIC VALUE ACCORDING TO ETHNIC ORIGIN AND CHRONIC VIRAL HEPATITIS C AND B ETIOLOGY Diagnostic value of FibroTest independent of ethnic origin FIBROTEST VALIDATIONS IN SPECIAL POPULATIONS P.HALFON AND AL; IMPACT OF ANTIVIRAL TREATMENT ON NON-INVASIVE PREDICTORS OF LIVER FIBROSIS IN HIV/HCV CO-INFECTED PATIENTS Longitudinal validation of FibroTest compared to biopsy in coinfected HIV/HCV patients (Independent study) P.CALES AND AL; BLOOD TESTS OF LIVER FIBROSIS IN PATIENTS COINFECTED WITH HIV AND HCV Independent validation of FibroTest compared to biopsy in HIV/HCV coinfected patients (Independent study) Y.MAOR AND AL; FIBROTEST OR FIBROSCAN FOR EVALUATION OF LIVER FIBROSIS IN HEMOPHILIA PATIENTS INFECTED WITH HEPATITIS C Independent validation of FibroTest in hemophiliac patients with Hepatitis C (Independent study) L.ALRIC AND AL; COMPARISON OF LIEVR STIFFNESS, FIBROTEST AND LIVER BIOPSY FOR THE ASSESSMENT OF LIVER FIBROSIS IN RENAL TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS C Independent validation of FibroTest and Fibroscan in renal transplant patients with Hepatitis C (Independent study) TO FIND OUT MORE: AASLD 2008 Abstracts and Posters (English): http://aasld.scientificposters.com/epsSearch.cfm |
|
| Home | About Us | Physicians | For Laboratory | For Patients | News and events | Scientific publications | Recearch and clinical trials |
| www.onliver.com provides important information to aid in the diagnosis and management of certain diseases and conditions. How this information is used to guide patient care is the responsibility of the physician. | |||||||